Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in...

Area of Science:

• Pediatric infectious diseases
• Epidemiology
• Microbiology

Background:

• Longitudinal surveillance of pediatric invasive pneumococcal disease (IPD) was conducted in Santiago, Chile.
• Data collection spanned from 1994 to 2007, encompassing a significant period before and after potential vaccine introductions.

Purpose of the Study:

• To characterize the epidemiology and clinical presentations of IPD in children.
• To identify age-specific predominant pneumococcal serotypes causing invasive disease.
• To analyze trends in serotype incidence and their relation to invasive versus carriage isolates.

Main Methods:

• Analysis of three datasets: IPD hospitalizations (1994-2007), bacteremia in febrile children (2000-2007), and nasopharyngeal carriage in newborns (followed to 23 months).
• Serotyping of pneumococcal isolates from invasive disease and nasopharyngeal samples.
• Statistical comparison of case fatality rates and serotype distribution between different patient groups.

Main Results:

• The majority of IPD cases (79.3%) occurred in children under 5 years old, with a peak incidence in those aged 6-35 months.
• Meningitis and sepsis were common in infants (0-5 months), with serotype 5 predominating, while bacteremic pneumonia (serotype 14) was frequent in older children (6-35 months).
• Serotype 5 was more common in hospitalized young children, whereas serotype 18C was overrepresented in ambulatory patients; invasive isolates showed overrepresentation of serotypes 14, 5, and 1 compared to nasopharyngeal carriage.

Conclusions:

• Clinical manifestations and dominant pneumococcal serotypes causing invasive disease are significantly influenced by patient age.
• Age-specific data are essential for understanding the burden and epidemiology of IPD.
• Findings highlight the need for age-tailored public health interventions against pneumococcal infections.